Academic Radiology
Volume 17, Issue 3 , Pages 282-290 , March 2010

Glioma Recurrence Versus Radiation Necrosis? A Pilot Comparison of Arterial Spin-Labeled, Dynamic Susceptibility Contrast Enhanced MRI, and FDG-PET Imaging

This study was presented at the 87th Scientific Assembly and Annual Meeting of the Radiological Society of North America in 2001.

  • Yelda Ozsunar, MD

      Affiliations

    • Department of Radiology, Adnan Menderes University, School of Medicine, Hastane Caddesi, Aydin, Turkey
    • Corresponding Author InformationAddress correspondence to: Y.O.
    • ,
  • Mark E. Mullins, MD, PhD

      Affiliations

    • Department of Radiology, Emory University, Atlanta, GA
    • ,
  • Kenneth Kwong, PhD

      Affiliations

    • Department of Radiology, Massachusetts General Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • ,
  • Fred H. Hochberg, MD

      Affiliations

    • Department of Neurology and Brain Tumor Center, Massachusetts General Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • ,
  • Christine Ament, MD

      Affiliations

    • Boston University Eye Associates, Trygve Gunderson Eye Center, Boston, MA
    • ,
  • Pamela W. Schaefer, MD

      Affiliations

    • Department of Radiology, Massachusetts General Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • ,
  • R. Gilberto Gonzalez, MD, PhD

      Affiliations

    • Department of Radiology, Massachusetts General Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • ,
  • Michael H. Lev, MD

      Affiliations

    • Department of Radiology, Massachusetts General Hospital, Boston, MA
    • Harvard Medical School, Boston, MA

Received 31 August 2009 ,Accepted 21 October 2009.

References 

  1. Langleben DD, Segall GM. PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med. 2000;41:1861–1867
  2. Kleihues P, Soylemezoglu F, Schauble B, et al. Histopathology, classification, and grading of gliomas. Glia. 1995;15:211–221
  3. Bénard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med. 2003;33:148–162
  4. Loeffler JS, Alexander E, Hochberg FH, et al. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys. 1990;19:1455–1462
  5. Mullins ME, Barest GD, Schaefer PW, et al. Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. AJNR Am J Neuroradiol. 2005;26:1967–1972
  6. Valk PE, Dillon WP. Radiation injury of the brain. AJNR Am J Neuroradiol. 1991;12:45–62
  7. Ricci PE, Karis JP, Heiserman JE, et al. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?. AJNR Am J Neuroradiol. 1998;19:407–413
  8. Kahn D, Follett KA, Bushnell DL, et al. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET. AJR Am J Roentgenol. 1994;163:1459–1465
  9. Kumar AJ, Leeds NE, Fuller GN, et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology. 2000;217:377–384
  10. Roberts HC, Roberts TP, Brasch RC, et al. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol. 2000;21:891–899
  11. Roberts HC, Roberts TP, Bollen AW, et al. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. Acad Radiol. 2001;8:384–391
  12. Lemort M, Canizares-Perez AC, Van der Stappen A, Kampouridis S. Progress in magnetic resonance imaging of brain tumours. Curr Opin Oncol. 2007;19:616–622
  13. Nelson SJ, Cha S. Imaging glioblastoma multiforme. Cancer J. 2003;9:134–145
  14. Puduvalli VK, Sawaya R. Antiangiogenesis—therapeutic strategies and clinical implications for brain tumors. J Neurooncol. 2000;50:189–200
  15. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol. 1992;3:65–71
  16. Okunieff P, Dols S, Lee J, et al. Angiogenesis determines blood flow, metabolism, growth rate, and ATPase kinetics of tumors growing in an irradiated bed: 31P and 2H nuclear magnetic resonance studies. Cancer Res. 1991;51:3289–3295
  17. Estrada G, González-Maya L, Celis-López MA, et al. Diagnostic approach in suspected recurrent primary brain tumors using (18)FDG-PET/MRI, perfusion MRI, visual and quantitative analysis, and three dimensional stereotactic surface projections. First experience in Mexico. Rev Esp Med Nucl. 2008;27:329–339
  18. Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol. 2000;21:901–909
  19. Fuss M, Wenz F, Scholdei R, et al. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. Int J Radiat Oncol Biol Phys. 2000;48:53–58
  20. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendroglimoas. AJNR Am J Neuroradiol. 2004;25:214–221
  21. Fitzek MM, Thornton AF, Rabinov JD, et al. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg. 1999;91:251–260
  22. Fitzek MM, Thornton AF, Harsh GT, et al. Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial. Int J Radiat Oncol Biol Phys. 2001;51:131–137
  23. Pardo FS, Aronen HJ, Fitzek M, et al. Correlation of FDG-PET interpretation with survival in a cohort of glioma patients. Anticancer Res. 2004;24:2359–2365
  24. Aronen HJ, Pardo FS, Kennedy DN, et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res. 2000;6:2189–2200
  25. Kwong KK, Chesler DA, Weisskoff RM, et al. MR perfusion studies with T1-weighted echo planar imaging. Magn Reson Med. 1995;34:878–887
  26. Petersen ET, Zimine I, Ho YC, Golay X. Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques. Br J Radiol. 2006;79:688–701
  27. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology. 1994;191:41–51
  28. Weisskoff R, Rosen BR. Functional magnetic resonance imaging. Acad Radiol. 1995;(suppl):133–135
  29. Lev MH, Rosen BR. Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin North Am. 1999;9:309–331
  30. Provenzale JM, Wang GR, Brenner T, Petrella JR, Sorensen AG. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol. 2002;178:711–716
  31. Covarrubias DJ, Rosen BR, Lev MH. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist. 2004;9:528–537
  32. Song CW, Lokshina A, Rhee JG. Implication of blood flow in hyperthermic treatment of tumors. IEEE Trans Biomed Eng. 1984;31:9–16
  33. Sadeghi N, Salmon I, Tang BN, et al. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results. J Magn Reson Imagin. 2006;24:989–994
  34. Spampinato MV, Smith JK, Kwock L, et al. Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors. AJR Am J Roentgenol. 2007;188:204–212
  35. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2∗-weighted MR imaging. Radiology. 1999;211:791–798
  36. Uematsu H, Maeda M, Sadato N, et al. Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. AJNR Am J Neuroradiol. 2001;22:1915–1919
  37. Aronen HJ, Perkio J. Dynamic susceptibility contrast MRI of gliomas. Neuroimaging Clin North Am. 2002;12:501–523
  38. Warmuth C, Gunther M, Zimmer C. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology. 2003;228:523–532
  39. Dean BL, Drayer BP, Bird CR, et al. Gliomas: classification with MR imaging. Radiology. 1990;174:411–415
  40. Bagley LJ, Grossman RI, Judy KD, et al. Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology. 1997;202:511–516
  41. Miralbell R, Lomax A, Russo M. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuro-ectodermal tumors: spinal theca irradiation. Int J Radiat Oncol Biol Phys. 1997;38:805–811
  42. Forsyth PA, Kelly PJ, Cascino TL, et al. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?. J Neurosurg. 1995;82:436–444
  43. Pauliah M, Saxena V, Haris M, Husain N, Rathore RK, Gupta RK. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma. Magn Reson Imaging. 2007;25:1292–1299
  44. Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol. 1998;171:1479–1486
  45. Aronen HJ, Glass J, Pardo FS, et al. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility. Acta Radiol. 1995;36:520–528
  46. Wolf RL, Wang J, Wang S, et al. Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla. J Magn Reson Imaging. 2005;22:475–482
  47. Gasparetto EL, Pawlak MA, Patel SH, et al. Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction. Radiology. 2009;250:887–896
  48. Calamante F, Thomas DL, Pell GS, et al. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab. 1999;19:701–735
  49. Cavuşoğlu M, Pfeuffer J, Uğurbil K, Uludağ K. Comparison of pulsed arterial spin labeling encoding schemes and absolute perfusion quantification. Magn Reson Imaging. 2009;27:1039–1045
  50. Gevers S, Majoie CB, van den Tweel XW, Lavini C, Nederveen AJ. Acquisition time and reproducibility of continuous arterial spin-labeling perfusion imaging at 3 T. AJNR Am J Neuroradiol. 2009;30:968–971

 This project was funded by a Seed Grant from the Radiological Society of North America (Oak Brook, IL) to Dr Lev.

PII: S1076-6332(09)00596-0

doi: 10.1016/j.acra.2009.10.024

Academic Radiology
Volume 17, Issue 3 , Pages 282-290 , March 2010

Article Tools

* Image Usage & Resolution